Tetragraph Neuromuscular Transmission Monitor— 510(k) K190795

Substantially Equivalent

Senzime AB

FDA 510(k) clearance K190795 for Tetragraph Neuromuscular Transmission Monitor, Substantially Equivalent on 2019-10-18. Applicant: Senzime AB.

Clearance details

Applicant: Senzime AB
Product code: Code KOI
Advisory panel: Anesthesiology
Date received: 2019-03-28
Decision date: 2019-10-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Uppsala, SE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.